Abstract
The prevention and treatment of addiction (moderate to severe substance use disorder—SUD) have remained challenging because of the dynamic and complex interactions between multiple biological and social determinants that shape SUD. The pharmacological landscape is ever changing and the use of multiple drugs is increasingly common, requiring an unraveling of pharmacological interactions to understand the effects. There are different stages in the trajectory from drug use to addiction that are characterized by distinct cognitive and emotional features. These are directed by different neurobiological processes that require identification and characterization including those that underlie the high co-morbidity with other disorders. Finally, there is substantial individual variability in the susceptibility to develop SUD because there are multiple determinants, including genetics, sex, developmental trajectories and times of drug exposures, and psychosocial and environmental factors including commercial determinants that influence drug availability. Elucidating how these factors interact to determine risk is essential for identifying the biobehavioral basis of addiction and developing prevention and treatment strategies. Basic research is tasked with addressing each of these challenges. The recent proliferation of technological advances that allow for genetic manipulation, visualization of molecular reactions and cellular activity in vivo, multiscale whole brain mapping across the life span, and the mining of massive data sets including multimodality human brain imaging are accelerating our ability to understand how the brain functions and how drugs influence it. Here, we highlight how the application of these tools to the study of addiction promises to illuminate its neurobiological basis and guide strategies for prevention and treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Aloisi F (2001) Immune function of microglia. Glia 36(2):165–179. https://doi.org/10.1002/glia.1106
Avey D, Sankararaman S, Yim AKY, Barve R, Milbrandt J, Mitra RD (2018) Single-cell RNA-seq uncovers a robust transcriptional response to morphine by glia. Cell Rep 24(13):3619-3629 e3614. https://doi.org/10.1016/j.celrep.2018.08.080
Baarendse PJ, Limpens JH, Vanderschuren LJ (2014) Disrupted social development enhances the motivation for cocaine in rats. Psychopharmacology 231(8):1695–1704. https://doi.org/10.1007/s00213-013-3362-8
Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO, Ledderose C, Kutlu MG, Wheeler MA, Kahan A, Ishikawa M, Wang YC, Loh YE, Jiang JX, Surmeier DJ, Robson SC, Junger WG, Sebra R, Calipari ES, Kenny PJ, Eyo UB, Colonna M, Quintana FJ, Wake H, Gradinaru V, Schaefer A (2020) Negative feedback control of neuronal activity by microglia. Nature 586(7829):417–423. https://doi.org/10.1038/s41586-020-2777-8
Bates ML, Emery MA, Wellman PJ, Eitan S (2014) Social housing conditions influence morphine dependence and the extinction of morphine place preference in adolescent mice. Drug Alcohol Depend 142:283–289. https://doi.org/10.1016/j.drugalcdep.2014.06.036
Becker JB, Koob GF (2016) Sex differences in animal models: focus on addiction. Pharmacol Rev 68(2):242–263. https://doi.org/10.1124/pr.115.011163
Casey BJ, Cannonier T, Conley MI, Cohen AO, Barch DM, Heitzeg MM, Soules ME, Teslovich T, Dellarco DV, Garavan H, Orr CA, Wager TD, Banich MT, Speer NK, Sutherland MT, Riedel MC, Dick AS, Bjork JM, Thomas KM, Chaarani B, Mejia MH, Hagler DJ Jr, Daniela Cornejo M, Sicat CS, Harms MP, Dosenbach NUF, Rosenberg M, Earl E, Bartsch H, Watts R, Polimeni JR, Kuperman JM, Fair DA, Dale AM, Workgroup AIA (2018) The Adolescent brain cognitive development (ABCD) study: imaging acquisition across 21 sites. Dev Cogn Neurosci 32:43–54. https://doi.org/10.1016/j.dcn.2018.03.001
Che T, Roth BL (2021) Structural insights accelerate the discovery of opioid alternatives. Annu Rev Biochem 90:739–761. https://doi.org/10.1146/annurev-biochem-061620-044044
Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll FI, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172(1–2):55-67 e15. https://doi.org/10.1016/j.cell.2017.12.011
Duncan A, Heyer MP, Ishikawa M, Caligiuri SPB, Liu XA, Chen Z, Micioni Di Bonaventura MV, Elayouby KS, Ables JL, Howe WM, Bali P, Fillinger C, Williams M, O’Connor RM, Wang Z, Lu Q, Kamenecka TM, Ma’ayan A, O’Neill HC, Ibanez-Tallon I, Geurts AM, Kenny PJ (2019) Habenular TCF7L2 links nicotine addiction to diabetes. Nature 574(7778):372–377. https://doi.org/10.1038/s41586-019-1653-x
Gould RW, Czoty PW, Porrino LJ, Nader MA (2017) Social status in monkeys: effects of social confrontation on brain function and cocaine self-administration. Neuropsychopharmacology 42(5):1093–1102. https://doi.org/10.1038/npp.2016.285
Harp SJ, Martini M, Lynch WJ, Rissman EF (2020) Sexual Differentiation and Substance Use: A Mini-Review. Endocrinology. https://doi.org/10.1210/endocr/bqaa129
Higgins C, Smith BH, Matthews K (2019) Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth 122(6):e114–e126. https://doi.org/10.1016/j.bja.2018.09.019
Hu M, Becker JB (2008) Acquisition of cocaine self-administration in ovariectomized female rats: effect of estradiol dose or chronic estradiol administration. Drug Alcohol Depend 94(1–3):56–62. https://doi.org/10.1016/j.drugalcdep.2007.10.005
Jerlhag E (2018) GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Neuropharmacology 136(Pt B):343–349. https://doi.org/10.1016/j.neuropharm.2018.01.013
Johnson EC, Demontis D, Thorgeirsson TE, Walters RK, Polimanti R, Hatoum AS, Sanchez-Roige S, Paul SE, Wendt FR, Clarke TK, Lai D, Reginsson GW, Zhou H, He J, Baranger DAA, Gudbjartsson DF, Wedow R, Adkins DE, Adkins AE, Alexander J, Bacanu SA, Bigdeli TB, Boden J, Brown SA, Bucholz KK, Bybjerg-Grauholm J, Corley RP, Degenhardt L, Dick DM, Domingue BW, Fox L, Goate AM, Gordon SD, Hack LM, Hancock DB, Hartz SM, Hickie IB, Hougaard DM, Krauter K, Lind PA, McClintick JN, McQueen MB, Meyers JL, Montgomery GW, Mors O, Mortensen PB, Nordentoft M, Pearson JF, Peterson RE, Reynolds MD, Rice JP, Runarsdottir V, Saccone NL, Sherva R, Silberg JL, Tarter RE, Tyrfingsson T, Wall TL, Webb BT, Werge T, Wetherill L, Wright MJ, Zellers S, Adams MJ, Bierut LJ, Boardman JD, Copeland WE, Farrer LA, Foroud TM, Gillespie NA, Grucza RA, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono WG, Johnson EO, Kendler KS, Kennedy MA, Kranzler HR, Madden PAF, Maes HH, Maher BS, Martin NG, McGue M, McIntosh AM, Medland SE, Nelson EC, Porjesz B, Riley BP, Stallings MC, Vanyukov MM, Vrieze S, Davis LK, Bogdan R, Gelernter J, Edenberg HJ, Stefansson K, Borglum AD, Agrawal A (2020) A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry 7(12):1032–1045. https://doi.org/10.1016/S2215-0366(20)30339-44
Jordan CJ, Weiss SR, Howlett KD, Freund MP (2020) Introduction to the special issue on “Informing Longitudinal Studies on the Effects of Maternal Stress and Substance Use on Child Development: Planning for the HEALthy Brain and Child Development (HBCD) Study.” Adver Resil Sci 1(4):217–221
Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000) Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57(3):261–269. https://doi.org/10.1001/archpsyc.57.3.261
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217–238. https://doi.org/10.1038/npp.2009.110
Kranzler HR, Zhou H, Kember RL, Vickers Smith R, Justice AC, Damrauer S, Tsao PS, Klarin D, Baras A, Reid J, Overton J, Rader DJ, Cheng Z, Tate JP, Becker WC, Concato J, Xu K, Polimanti R, Zhao H, Gelernter J (2019) Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun 10(1):1499. https://doi.org/10.1038/s41467-019-09480-8
Kruyer A, Chioma VC, Kalivas PW (2020) The opioid-addicted tetrapartite synapse. Biol Psychiatry 87(1):34–43. https://doi.org/10.1016/j.biopsych.2019.05.025
Kruyer A, Angelis A, Garcia-Keller C, Li H, Kalivas PW (2022) Plasticity in astrocyte subpopulations regulates heroin relapse. Sci Adv 8(32):eabo7044. https://doi.org/10.1126/sciadv.abo7044
Levis SC, Bentzley BS, Molet J, Bolton JL, Perrone CR, Baram TZ, Mahler SV (2021) On the early life origins of vulnerability to opioid addiction. Mol Psychiatry 26(8):4409–4416. https://doi.org/10.1038/s41380-019-0628-5
Levis SC, Birnie MT, Bolton JL, Perrone CR, Montesinos JS, Baram TZ, Mahler SV (2022) Enduring disruption of reward and stress circuit activities by early-life adversity in male rats. Transl Psychiatry 12(1):251. https://doi.org/10.1038/s41398-022-01988-w
Lutz PE, Ayranci G, Chu-Sin-Chung P, Matifas A, Koebel P, Filliol D, Befort K, Ouagazzal AM, Kieffer BL (2014) Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence. Neuropsychopharmacology 39(11):2694–2705. https://doi.org/10.1038/npp.2014.126
Martini M, Irvin JW, Lee CG, Lynch WJ, Rissman EF (2020) Sex chromosome complement influences vulnerability to cocaine in mice. Horm Behav 125:104821. https://doi.org/10.1016/j.yhbeh.2020.104821
Mathis V, Kenny PJ (2019) From controlled to compulsive drug-taking: the role of the habenula in addiction. Neurosci Biobehav Rev 106:102–111. https://doi.org/10.1016/j.neubiorev.2018.06.018
Miczek KA, Nikulina EM, Shimamoto A, Covington HE 3rd (2011) Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. J Neurosci 31(27):9848–9857. https://doi.org/10.1523/JNEUROSCI.0637-11.2011
Morales M, Margolis EB (2017) Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci 18(2):73–85. https://doi.org/10.1038/nrn.2016.165
Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26(10):523–530. https://doi.org/10.1016/j.tins.2003.08.008
Newman EL, Leonard MZ, Arena DT, de Almeida RMM, Miczek KA (2018) Social defeat stress and escalation of cocaine and alcohol consumption: focus on CRF. Neurobiol Stress 9:151–165. https://doi.org/10.1016/j.ynstr.2018.09.007
NIDA (2020) Common comorbidities with substance use disorders research report. National Institutes on Drug Abuse, Bethesda, MD
Ordones Sanchez E, Bavley CC, Deutschmann AU, Carpenter R, Peterson DR, Karbalaei R, Flowers J 2nd, Rogers CM, Langrehr MG, Ardekani CS, Famularo ST, Bongiovanni AR, Knouse MC, Floresco SB, Briand LA, Wimmer ME, Bangasser DA (2021) Early life adversity promotes resilience to opioid addiction-related phenotypes in male rats and sex-specific transcriptional changes. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.2020173118
Perry AN, Westenbroek C, Becker JB (2013) The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PLoS ONE 8(11):e79465. https://doi.org/10.1371/journal.pone.0079465
Pomrenze MB, Cardozo Pinto DF, Neumann PA, Llorach P, Tucciarone JM, Morishita W, Eshel N, Heifets BD, Malenka RC (2022) Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal. Neuron 110(24):4125-4143 e4126. https://doi.org/10.1016/j.neuron.2022.09.024
Provenza NR, Sheth SA, Dastin-van Rijn EM, Mathura RK, Ding Y, Vogt GS, Avendano-Ortega M, Ramakrishnan N, Peled N, Gelin LFF, Xing D, Jeni LA, Ertugrul IO, Barrios-Anderson A, Matteson E, Wiese AD, Xu J, Viswanathan A, Harrison MT, Bijanki KR, Storch EA, Cohn JF, Goodman WK, Borton DA (2021) Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorder. Nat Med 27(12):2154–2164. https://doi.org/10.1038/s41591-021-01550-z
Radoux-Mergault A, Oberhauser L, Aureli S, Gervasio FL, Stoeber M (2023) Subcellular location defines GPCR signal transduction. Sci Adv 9(16):eadf6059. https://doi.org/10.1126/sciadv.adf6059
Ramoa CP, Doyle SE, Naim DW, Lynch WJ (2013) Estradiol as a mechanism for sex differences in the development of an addicted phenotype following extended access cocaine self-administration. Neuropsychopharmacology 38(9):1698–1705. https://doi.org/10.1038/npp.2013.68
Reiner BC, Zhang Y, Stein LM, Perea ED, Arauco-Shapiro G, Ben Nathan J, Ragnini K, Hayes MR, Ferraro TN, Berrettini WH, Schmidt HD, Crist RC (2022) Single nucleus transcriptomic analysis of rat nucleus accumbens reveals cell type-specific patterns of gene expression associated with volitional morphine intake. Transl Psychiatry 12(1):374. https://doi.org/10.1038/s41398-022-02135-1
Ribeiro JML, Filizola M (2019) Insights from molecular dynamics simulations of a number of g-protein coupled receptor targets for the treatment of pain and opioid use disorders. Front Mol Neurosci 12:207. https://doi.org/10.3389/fnmol.2019.00207
Rincon-Cortes M (2023) Sex differences in addiction-relevant behavioral outcomes in rodents following early life stress. Addict Neurosci. https://doi.org/10.1016/j.addicn.2023.100067
Root DH, Barker DJ, Estrin DJ, Miranda-Barrientos JA, Liu B, Zhang S, Wang HL, Vautier F, Ramakrishnan C, Kim YS, Fenno L, Deisseroth K, Morales M (2020) Distinct signaling by ventral tegmental area glutamate, GABA, and combinatorial glutamate-GABA neurons in motivated behavior. Cell Rep 32(9):108094. https://doi.org/10.1016/j.celrep.2020.108094
Sey NYA, Hu B, Iskhakova M, Lee S, Sun H, Shokrian N, Ben Hutta G, Marks JA, Quach BC, Johnson EO, Hancock DB, Akbarian S, Won H (2022) Chromatin architecture in addiction circuitry identifies risk genes and potential biological mechanisms underlying cigarette smoking and alcohol use traits. Mol Psychiatry 27(7):3085–3094. https://doi.org/10.1038/s41380-022-01558-y
Singh I, Seth A, Billesbolle CB, Braz J, Rodriguiz RM, Roy K, Bekele B, Craik V, Huang XP, Boytsov D, Pogorelov VM, Lak P, O’Donnell H, Sandtner W, Irwin JJ, Roth BL, Basbaum AI, Wetsel WC, Manglik A, Shoichet BK, Rudnick G (2023) Structure-based discovery of conformationally selective inhibitors of the serotonin transporter. Cell 186(10):2160-2175 e2117. https://doi.org/10.1016/j.cell.2023.04.010
Sounier R, Mas C, Steyaert J, Laeremans T, Manglik A, Huang W, Kobilka BK, Demene H, Granier S (2015) Propagation of conformational changes during mu-opioid receptor activation. Nature 524(7565):375–378. https://doi.org/10.1038/nature14680
Stoeber M, Jullie D, Lobingier BT, Laeremans T, Steyaert J, Schiller PW, Manglik A, von Zastrow M (2018) A genetically encoded biosensor reveals location bias of opioid drug action. Neuron 98(5):963-976 e965. https://doi.org/10.1016/j.neuron.2018.04.021
Teschemacher AG, Gourine AV, Kasparov S (2015) A role for astrocytes in sensing the brain microenvironment and neuro-metabolic integration. Neurochem Res 40(12):2386–2393. https://doi.org/10.1007/s11064-015-1562-9
Tuesta LM, Chen Z, Duncan A, Fowler CD, Ishikawa M, Lee BR, Liu XA, Lu Q, Cameron M, Hayes MR, Kamenecka TM, Pletcher M, Kenny PJ (2017) GLP-1 acts on habenular avoidance circuits to control nicotine intake. Nat Neurosci 20(5):708–716. https://doi.org/10.1038/nn.4540
Uchanski T, Pardon E, Steyaert J (2020) Nanobodies to study protein conformational states. Curr Opin Struct Biol 60:117–123. https://doi.org/10.1016/j.sbi.2020.01.003
Vargas MV, Dunlap LE, Dong C, Carter SJ, Tombari RJ, Jami SA, Cameron LP, Patel SD, Hennessey JJ, Saeger HN, McCorvy JD, Gray JA, Tian L, Olson DE (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379(6633):700–706. https://doi.org/10.1126/science.adf0435
Venniro M, Marino RAM, Chow JJ, Caprioli D, Epstein DH, Ramsey LA, Shaham Y (2022) The protective effect of social reward on opioid and psychostimulant reward and relapse: behavior, pharmacology, and brain regions. J Neurosci 42(50):9298–9314. https://doi.org/10.1523/JNEUROSCI.0931-22.2022
Volkow ND (2020) Collision of the COVID-19 and addiction epidemics. Ann Intern Med 173(1):61–62. https://doi.org/10.7326/M20-1212
Volkow ND, Blanco C (2021) The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry 26(1):218–233. https://doi.org/10.1038/s41380-020-0661-4
Volkow ND, Wise RA, Baler R (2017) The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 18(12):741–752. https://doi.org/10.1038/nrn.2017.130
Wang J, Holt LM, Huang HH, Sesack SR, Nestler EJ, Dong Y (2022) Astrocytes in cocaine addiction and beyond. Mol Psychiatry 27(1):652–668. https://doi.org/10.1038/s41380-021-01080-7
Wei J, Lambert TY, Valada A, Patel N, Walker K, Lenders J, Schmidt CJ, Iskhakova M, Alazizi A, Mair-Meijers H, Mash DC, Luca F, Pique-Regi R, Bannon MJ, Akbarian S (2023) Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder. Nat Commun 14(1):5610. https://doi.org/10.1038/s41467-023-41455-8
Yang J, Chen J, Liu Y, Chen KH, Baraban JM, Qiu Z (2023) Ventral tegmental area astrocytes modulate cocaine reward by tonically releasing GABA. Neuron 111(7):1104-1117 e1106. https://doi.org/10.1016/j.neuron.2022.12.033
Young JZ (1991) The concept of neuroglia. Ann N Y Acad Sci 633:1–18. https://doi.org/10.1111/j.1749-6632.1991.tb15590.x
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Valentino, R.J., Nair, S.G. & Volkow, N.D. Neuroscience in addiction research. J Neural Transm 131, 453–459 (2024). https://doi.org/10.1007/s00702-023-02713-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-023-02713-7